PAK1 and hepatocellular carcinoma: Consistent with our previous studies indicating the pivotal significance of PAK1-induced anoikis resistance in HBV-associated hepatocarcinogenesis, our current data also indentify VEGFR2/PAK1 activation as downstream effector of Klotho expression in anoikis resistance of hepatoma cells.